Top 10 Pharmaceutical Penny Stocks List

Pharmaceutical Penny Stock

Many stock analysts agree that with aging US population, increased FDA approval of many novel drugs and exponential growth of prescription drugs sales are bound to increase investors’ interest in pharmaceutical penny stocks. Now is a great time to look into some of the hot penny stocks lists to buy into the market before their prices start increasing. Did you know that as of 2014 according to Forbes, eight out of nine top successful penny stocks were from the biotech and medical industries?

Please check out our selection of pharmaceutical penny stocks to watch below.

1. Prana Biotechnology (PRAN)
This is a company heavily involved in the research phase and development of PBT2 drug to treat Alzheimer’s disease that currently has no cure. Like with all pharmaceuticial penny stocks, depending on the research and whether the drug is going to take off, it is purely a bet whether PBT2 will actually enter the market. The researchers are betting on a theory that the disease is purely caused by the build up of amyloid plague that interacts with zinc and copper compounds in the brain triggering a chain reaction of events. The progression of the disease could be stopped by breaking up the chemical reaction, which should return brain activity to normal.

2. Orexigen Therapeutics (OREX)
This is a company that has developed a weight loss solution medicine Contrave. If the drug reaches FDA approval, the company could end up among penny stock success stories to tell.

3. IsoRay Inc. (ISR)
This is one of the best penny stocks to buy right now because it is working on manufacturing brachytherapy seeds necessary for the treatment of a wide array of cancers including prostate, lung, pelvic, colorectal, etc. The company projected its pharmaceutical penny stocks prices to reach the targeted number of $5 per share by the end of the year.

4. Athersys, Inc. (ATHS)
Athersys offers biotech penny stocks. The company is involved in the production and development of several drugs for weight loss, attention span disorders and narcolepsy. The stocks are trading at an average volume of 800K over the last 30 days.

5. Catalyst Pharmaceutical Partners (CPRX)
Currently traded on NASDAQ this small cap pharmaceutical company specializes on the development of several drugs targeting central nervous system, specifically to treat nervous disorders, addictions and epilepsy. Another focus is participating in the stage III for developing a drug to help people with rare autoimmune disorders affecting their muscles and central nervous system.

6. Rexahn Pharmaceuticals, Inc. (RNN)
Rexahn is also working on several medications for patients affected by diseases of the central nervous system and cancer. In fact, three of their drugs, namely, Serdaxin, Zoraxel and Archexin are in the clinical trials stages promising great returns for their investors.

7. Cyclacel Pharmaceuticals, Inc. (CYCC)
Cyclacel Pharmaceuticals is among top pharmaceutical penny stocks to consider because the company is focused on research and development of several drugs to treat cancer. With so many new patients getting diagnosed with this deadly disease daily, any small cap company contributing to this industry is worth looking into. Their unique small molecule drugs are thought to stop uncontrollable cell division typical with leukemia and other forms of cancer.

8. Luna Innovations, Inc. (LUNA)
Luna stands out among medical penny stock companies working on developing Nano technological medicines designed for diagnosis and targeted treatment of many human health conditions using highly innovative carbon nanomaterial. Besides drugs, the company is involved in medical supply and technologies creating a well diversified pharmaceutical penny stocks to invest into.

9. Neuralstem (CUR)
Neuralstem offers very promising pharmaceutical penny stocks due to working in several directions in finding cures for many deadly disease including injuries, cancers and others. CUR works on the stem cell transplantation technologies and also on molecular drugs to control abnormal cell division.

10. Columbia Laboratories (CBRX)
The company specializes on novel drugs development, molecular and bio-adhesive technologies. The company currently offers a number of products to the pharma market, including progesterone and testosterone cream and suppositories, extended release pain medications.